Events Archive
 
Email Page
June 26, 2018
ACI 9th Annual Summit on Biosimilars
June 25, 2018
Monopoly Leveraging: Is It Making A Comeback?
June 20, 2018
ABA Monthly Antitrust Update Program for In-House Counsel June 2018
June 19, 2018
A New Wave? Vertical Transactions in Healthcare Antitrust
June 12, 2018
35 U.S.C. 103 and the CAFC from District Courts
June 11, 2018
2018 CBA Annual Connecticut Legal Conference
June 11, 2018
Antitrust Policy in the New Administration
June 7, 2018
GCR 6th Annual Live Conference
June 1, 2018
Innovation in High Tech: Is Antitrust Policy Helping?
May 23, 2018
eDiscovery and Data Protection: The Ethical Issues
May 15, 2018
Centerforce 4th Annual IP Strategy Summit - Boston
May 9, 2018
The Capitol Forum Antitrust Law Leaders
May 8, 2018
The Hart-Scott Rodino Act: What You Should Know
May 3, 2018
2018 FDLI Annual Conference
April 26, 2018
Hard Topics in Antitrust Risk Allocation
April 23, 2018
ACI 12th Annual Paragraph IV Disputes Conference
April 11, 2018
ABA 66th Annual Section of Antitrust Law Spring Meeting
March 28, 2018
How Cyber Insurance Can Reduce Fraud and Incentivize Best Practices
March 27, 2018
DSRIP Antitrust Considerations: The Case for a COPA
March 8, 2018
ACI 31st Annual FDA Bootcamp
February 28, 2018
Relationship of Antitrust Law and Intellectual Property
February 23, 2018
ACI 8th Annual Advanced Summit on Medical Device and MedTech Patents
February 23, 2018
The Federal Circuit Relaxes the Rules on Proving Divided Infringement
February 22, 2018
ABA Monthly Antitrust Update Program for In-House Counsel February 2018
February 21, 2018
Damages Under State Trade Secret Laws and The Defend Trade Secrets Act of 2016
February 21, 2018
Observations from a U.S. Jury Trial
February 20, 2018
Distribution Fundamental Series: Horizontal Arrangements
February 20, 2018
Document Management Policies: Reducing Future Litigation Risk & Cost
February 19, 2018
Big Data and U.S. Antitrust Policy
February 7, 2018
ABA Section of Antitrust Law State AG Merger Enforcement
February 1, 2018
Hot Topics and Issues in the Biosimilars Space: Part Two
January 25, 2018
NYSBA 141st Annual Meeting
January 18, 2018
Two Years Later: The eDiscovery Amendments
December 19, 2017
FDA Medical Device Approval Under the New Administration
December 11, 2017
Coordination of Global Merger Reviews
December 6, 2017
Ethics and Intellectual Property Traps, Pitfalls and Adventures in IP Lawyering (2017)
November 16, 2017
14th Annual eDiscovery Institute
November 14, 2017
The Essentials of Depositions
November 10, 2017
Here and Now: Biosimilars for the Treatment of IBD
November 1, 2017
2017 World Biosimilar Congress Europe
October 17, 2017
Cyber Security Laws & Trends in U.S.
October 11, 2017
Cyber Risk and Liability Insurance: What Is It and Why You Need It
October 5, 2017
Connecticut Science Center Axinn Sponsorship
October 4, 2017
FDLI Introduction to U.S. Biologics and Biosimilars Law and Regulation (2017)
October 1, 2017
Regulatory Review of Joint Ventures Between Competitors in the U.S.
September 18, 2017
Aspen Skiing: Do You Have to Have Danced Before?
September 13, 2017
2017 AAM Biosimilars Council Conference
August 30, 2017
Managing Your IP Spend: Containing Costs and Maintaining Quality
August 11, 2017
Actions to Recover Antitrust Damages
August 9, 2017
Key Regulatory Issues in Biosimilars
July 19, 2017
ACI 4th Annual Women Leaders in Life Sciences Law Conference
June 14, 2017
2017 Centerforce Women in IP & Law Summit - Silicon Valley
June 12, 2017
2017 CBA Annual Connecticut Legal Conference
June 12, 2017
ACI 8th Annual Summit on Biosimilars
June 6, 2017
GCR 3rd Annual Live Antitrust Litigation USA Conference
May 23, 2017
2017 World Biosimilar Congress USA
May 11, 2017
Magna’s Mock Crisis; Part III
May 10, 2017
ACI 3rd Annual Post Grant PTO Proceedings Conference
May 10, 2017
Operating Company vs Operating Company Litigation: A Proactive Defense
May 4, 2017
2017 FDLI Annual Conference
April 30, 2017
Litigation Funding Fails: How & Why Law Firms & Funders Came Dangerously Unstuck In Cases Gone Wrong
April 25, 2017
2017 WEX Health Partner Conference
April 5, 2017
Emerging Trends in Antitrust Enforcement
March 30, 2017
The Capitol Forum 5th Annual Antitrust Thought Leaders Interview Series
March 29, 2017
Antitrust Enforcement in China: Developing Successful and Coherent Antitrust Strategy for Multinational Corporations
March 23, 2017
ACI 29th Annual FDA Boot Camp
March 21, 2017
Securing Your First Law Firm Job: Insights and Tips
March 16, 2017
Centerforce 2nd Annual Trademark & Copyright Summit
March 3, 2017
Antitrust Practice Workshop: The Big Deal
March 1, 2017
ACI 7th Annual Advanced Summit on Medical Device and MedTech Patents
January 31, 2017
2017 ACC Foundation Cybersecurity Summit
January 31, 2017
IP Practice in Japan Pre-Meeting: IPR Estoppels in Litigation
January 30, 2017
Intellectual Property Essentials for Entrepreneurs
January 24, 2017
Slaughter and May Competition Counsel Day
January 12, 2017
Judicial Clerkships: Why You May Want to Consider Applying for One
December 6, 2016
FDA's New Final Rule Implementing the MMA and Amending ANDA and 505(b)(2) Practice
November 15, 2016
Centerforce 4th Annual IP Strategy Summit - Silicon Valley
November 15, 2016
The Role of Factual Disputes in PTAB Institution Decisions in the Life Sciences
October 27, 2016
Aligning Your Enforcement Strategy with Business Goals
October 26, 2016
IP Practice in Japan Pre-Meeting: Defend Trade Secrets Act
October 20, 2016
FDLI Introduction to Drug Law and Regulation (2016)
October 4, 2016
U.S. Criminal Antitrust Enforcement: An Update
July 28, 2016
ACI 3rd Annual Women Leaders in Life Sciences Law Conference
June 16, 2016
Why Antitrust?
June 13, 2016
ACI 7th Annual Summit on Biosimilars
June 8, 2016
IBA 15th Annual International Mergers & Acquisitions Conference
June 7, 2016
GCR 2nd Annual Live Antitrust Litigation USA Conference
June 2, 2016
Breaking Through "The Bamboo Ceiling"
May 23, 2016
The Abbreviated NDA (ANDA), 505(b)(2) Applications and Patent and Exclusivity Issues (2016)
May 10, 2016
KSR and 103: Tools You Can Use?
May 6, 2016
Ploy or Policy Tool: A Look at the Citizen Petition Process
April 10, 2016
Handling Data Breaches When – Not If – They Happen
April 6, 2016
ABA 64th Annual Section of Antitrust Law Spring Meeting
March 17, 2016
Anatomy of a PTO PTAB Patent Trial
March 16, 2016
The FTC's Section 5 Unfair Competition Guidelines Demystified
March 11, 2016
ACI 27th Annual FDA Boot Camp
March 7, 2016
ABA Monthly Antitrust Update Program For In-House Counsel February 2016
February 29, 2016
Hot Topics and Issues in the Biosimilars Space: Part One
February 11, 2016
SCOTUS Update: Impact of Halo and Stryker on Enhanced Patent Damages Assessments
February 1, 2016
NYSBA 139th Annual Meeting
January 22, 2016
2016 DAGA Winter Policy Conference
December 15, 2015
Multistate Indirect Purchaser Class Actions: Using Consumer Protection Statutes to Hurdle the Illinois Brick Wall
November 6, 2015
The Role of In-House Counsel in Preparing for Trial
October 20, 2015
The Abbreviated NDA (ANDA), 505(b)(2) Applications and Patent and Exclusivity Issues (2015)
October 19, 2015
2015 IEEE-SIIT Conference
October 2015
DOJ Antitrust Division Staff Training Session
September 18, 2015
Cyber Security and Lawsuits – The Tip of the Iceberg
September 10, 2015
Cybersecurity Litigation and the Role of Cyber Insurance
September 8, 2015
GCR Live 3rd Annual New York Conference
September 2, 2015
2015 First Chair Awards
August 20, 2015
Seven Years in Beijing: China's Merger Reviews Under the Anti-Monopoly Law
July 23, 2015
ACI 2nd Annual Women Leaders in Life Sciences Law Conference
June 1, 2015
2015 GMU Annual Global Antitrust Economics Conference
June 1, 2015
ACI 6th Annual Summit on Biosimilars
May 29, 2015
FDLI Introduction to Drug Law and Regulation (2015)
May 29, 2015
The FTAIA Before the Supreme Court – Recent Developments in International Antitrust
May 2015
FTC Staff Training Session
April 27, 2015
ACI 9th Annual Paragraph IV Disputes Conference
April 22, 2015
How to Break Your Adversary Without Breaking the Bank: IP Litigation Strategies
April 15, 2015
ABA 63rd Annual Section of Antitrust Law Spring Meeting
March 26, 2015
Going To Trial: Enforcement Focused Strategies
March 11, 2015
ACI 24th Annual FDA Boot Camp
February 25, 2015
HCT/P: FDA’s Newest Regulatory Battleground
February 4, 2015
Why Staples May Be Allowed to Buy Office Depot
December 3, 2014
Taking Stock of the State Action Doctrine In Light of North Carolina Board of Dental Examiners v. FTC
September 19, 2014
Hot Issues in Intellectual Property
September 16, 2014
GCR Live 2nd Annual New York Conference
September 9, 2014
A Single Merger Control Standard for the US and Abroad?
September 2014
Employment Contracts: What to Look For and How to Negotiate Them
August 2014
The Abbreviated NDA (ANDA), 505(b)(2) Applications and Patent and Exclusivity Issues (2014)
June 5, 2014
Demonstrating Biosimilarity: Guidance from the FDA
March 13, 2014
Marketing Exclusivities: Challenges, Opportunities and Current Controversies
January 27, 2014
FDLI Introduction to Drug Law and Regulation (2014)
January 9, 2014
Hot Topics in Generic Drug Entry and Regulation
November 14, 2013
2013 NYSBA Antitrust Section Annual Meeting
November 1, 2013
2013 PLI Antitrust Counseling & Compliance Conference
June 28, 2013
Retrospective Analysis of Agency Determinations in Merger Transactions
June 27, 2013
Patent Hold-Up and Standard Essential Patents at the ITC: An Examination of Key Issues for Smartphone Manufacturers Engaged in Litigation at the ITC
June 13, 2013
Chicago Forum on International Antitrust Issues: Antitrust Perspective on Innovation, New Product Development, Standard Setting and Licensing
June 6, 2013
2013 ACI Biosimilars Conference
June 6, 2013
Financier Worldwide International Arbitration Roundtable
May 7, 2013
ACI 7th Annual Paragraph IV Disputes Conference
May 1, 2013
FDLI Introduction to Drug Law and Regulation (2013)
April 23, 2013
2013 FDLI Annual Conference
April 23, 2013
Trading in Secrets: Dealing with Employee and Data Mobility
March 27, 2013
Antitrust in the Obama Second Term: What to Expect
March 20, 2013
Bioequivalence: What Patent Lawyers Need to Know
March 5, 2013
Litigation and Prosecution Perspectives on The Obviousness of Medical Devices

View Current Events ›